REGN News

Securities Fraud Class Action Filed Against Regeneron Pharmaceuticals, Inc. (REGN) - Levi & Korsinsky Reminds Investors of September 14, 2026

Class Action Lawsuit Reminder from Pomerantz LLP for Shareholders of Regeneron Pharmaceuticals, Inc. – REGN

Lost Money on Regeneron Pharmaceuticals, Inc. (REGN)? Join Class Action Before September 14, 2026 – Contact Levi & Korsinsky

Bronstein, Gewirtz & Grossman LLC Urges Regeneron Pharmaceuticals, Inc. Investors to Act: Class Action Filed Alleging Investor Harm

Investors Urged to Contact Levi & Korsinsky for Information Before September 14, 2026 – Regeneron Pharmaceuticals, Inc. (REGN)

Pomerantz LLP Notifies Shareholders of Class Action Against Regeneron Pharmaceuticals, Inc. – REGN

Lost Money on Regeneron Pharmaceuticals, Inc. (REGN)? Urged to Join Class Action Before September 14, 2026 – Contact Levi & Korsinsky

REGN INVESTOR DEADLINE TOMORROW: Regeneron Pharmaceuticals, Inc. Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit, Robbins Geller Rudman & Dowd LLP Announces

Contact Levi & Korsinsky by September 14, 2026 to Join Class Action Against Regeneron Pharmaceuticals, Inc. (REGN)

REGN INVESTOR DEADLINE APPROACHING: Faruqi & Faruqi, LLP Reminds Regeneron (REGN) Investors of Securities Class Action Lawsuit Deadline on September 14, 2026